Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Non-invasive Autonomic Neuromodulation Is Opening New Landscapes for Cardiovascular Diseases.Frontiers in physiology · 2020
   Pooled it
2. Heart attack patients with complications. Treat with valsartan, captopril, or both?Canadian family physician Medecin de famille canadien · 2004
   Trial
3. NEUROMODULATION OF THE FAILING HEART: LOST IN TRANSLATION?JACC. Basic to translational science · 2016
   Article
4. TGF-β1, released by myofibroblasts, differentially regulates transcription and function of sodium and potassium channels in adult rat ventricular myocytes.PloS one · 2013
   Article
5. More about the "ARB MI paradox".Heart (British Cardiac Society) · 2007
   Article
6. Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b.Theoretical biology & medical modelling · 2006
   Article
7. Building on the specialist's antihypertensive treatment recommendation: it's just the beginning.Journal of clinical hypertension (Greenwich, Conn.) · 2006
   Review
8. Heart failure and shock complicating acute coronary syndromes.Current cardiology reports · 2005
   Review
9. Valsartan in acute myocardial infarction trial.Current cardiology reports · 2004
   Article
10. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.Heart failure reviews · 2004
    Review

Corrections and comments

• Comment on
  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.2003

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as